Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPBAR1 | Q8TDU6 | 11/20 | 0.69 |
| ▸ | NR1H4 | Q96RI1 | 4/20 | 0.69 |
| ▸ | PDE3A | Q14432 | 2/20 | 0.69 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.69 |
| ▸ | SLC10A2 | Q12908 | 1/20 | 0.69 |
| ▸ | MAPT | P10636 | 3/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.56 |
| ▸ | USP2 | O75604 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.55 |
| ▸ | CASP7 | P55210 | 3/20 | 0.55 |
| ▸ | TP53 | P04637 | 2/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.55 |
| ▸ | BLM | P54132 | 2/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.55 |
| ▸ | MDM4 | O15151 | 1/20 | 0.55 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.55 |
| ▸ | VDR | P11473 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21594795 | 0.91 | GPBAR1 (0.76) | GPBAR1NR1H4PDE3ATBXA2RSLC10A2 | |
| SCHEMBL7756845 | 0.91 | GPBAR1 (0.76) | GPBAR1NR1H4PDE3ATBXA2RSLC10A2 | |
| SCHEMBL1654288 | 0.91 | GPBAR1 (0.76) | GPBAR1NR1H4PDE3ATBXA2RSLC10A2 | |
| SCHEMBL3447484 | 0.91 | GPBAR1 (0.76) | GPBAR1NR1H4PDE3ATBXA2RSLC10A2 | |
| SCHEMBL21631677 | 0.91 | GPBAR1 (0.76) | GPBAR1NR1H4PDE3ATBXA2RSLC10A2 | |
| SCHEMBL7996290 | 0.88 | GPBAR1 (0.72) | GPBAR1NR1H4PDE3ATBXA2RSLC10A2 | |
| SCHEMBL476519 | 0.87 | GPBAR1 (0.73) | GPBAR1NR1H4PDE3ATBXA2RSLC10A2 | |
| SCHEMBL476518 | 0.87 | GPBAR1 (0.73) | GPBAR1NR1H4PDE3ATBXA2RSLC10A2 | |
| SCHEMBL1635362 | 0.87 | GPBAR1 (0.71) | GPBAR1NR1H4PDE3ATBXA2RSLC10A2 | |
| SCHEMBL759713 | 0.86 | GPBAR1 (0.71) | GPBAR1NR1H4PDE3ATBXA2RSLC10A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2296039-B1 | Positive photosensitive composition | FUJIFILM CORP (JP) | 2013-09-25 | — | — | EP | claimed |
| CN-113363141-A | Photoresist composition and method for manufacturing semiconductor device | 台湾积体电路制造股份有限公司 | 2021-09-07 | — | — | CN | disclosed |
| CN-110609441-A | Method for forming photoresist pattern | 台湾积体电路制造股份有限公司 | 2019-12-24 | — | — | CN | disclosed |
| EP-1961739-B1 | NOVEL COMPOUND, POLYMER, AND RESIN COMPOSITION | JSR CORP (JP) | 2012-10-17 | — | — | EP | disclosed |
| US-8273837-B2 | Compound, polymer, and resin composition | JSR CORPORATION (JP) | 2012-09-25 | — | — | US | disclosed |
| US-20090318652-A1 | NOVEL COMPOUND, POLYMER, AND RESIN COMPOSITION | JSR CORPORATION (JP) | 2009-12-24 | — | — | US | disclosed |
| US-20090305161-A1 | LIQUID IMMERSION LITHOGRAPHY | JSR CORPORATION (JP) | 2009-12-10 | — | — | US | disclosed |
| US-7615337-B2 | Photoactive resist capping layer | INTEL CORPORATION (US) | 2009-11-10 | — | — | US | disclosed |
| EP-1961739-A1 | NOVEL COMPOUND, POLYMER, AND RESIN COMPOSITION | JSR Corporation (JP) | 2008-08-27 | — | — | EP | disclosed |
| EP-1953595-A1 | RADIATION-SENSITIVE RESIN COMPOSITION | JSR Corporation (JP) | 2008-08-06 | — | — | EP | disclosed |
| EP-1035437-B1 | A radiation-sensitive resist material and a process for device fabrication using the same | LUCENT TECHNOLOGIES INC (US) | 2002-03-27 | — | — | EP | disclosed |
| US-6296984-B1 | PHOTORESISTS LIGHT SENSITIVE LAYERS ON A SUBSTRATE WITH CHROMOPHORE OF IODINIUM AND SULFONIUM GROUPS | AGERE SYSTEMS GUARDIAN CORP. | 2001-10-02 | — | — | US | disclosed |
| US-6258508-B1 | PHOTORESISTS | KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2001-07-10 | — | — | US | disclosed |
| EP-1035437-A2 | A radiation-sensitive resist material and a process for device fabrication using the same | LUCENT TECHNOLOGIES INC. (US) | 2000-09-13 | — | — | EP | disclosed |
| US-6013413-A | Alicyclic nortricyclene polymers and co-polymers | CORNELL RESEARCH FOUNDATION, INC. (US) | 2000-01-11 | — | — | US | disclosed |
| US-5998099-A | Energy-sensitive resist material and a process for device fabrication using an energy-sensitive resist material | LUCENT TECHNOLOGIES INC. (US) | 1999-12-07 | — | — | US | disclosed |
| EP-0880074-B1 | An energy-sensitive resist material and a process for device fabrication using an energy-sensitive resist material | LUCENT TECHNOLOGIES INC (US) | 1999-10-27 | — | — | EP | disclosed |
| EP-0907109-A1 | Process for device fabrication using a radiation-sensitive resist material | LUCENT TECHNOLOGIES INC. (US) | 1999-04-07 | — | — | EP | disclosed |
| US-5879857-A | POLYMER, PHOTOACID GENERATOR, DISSOLUTION INHIBITOR | LUCENT TECHNOLOGIES INC. (US) | 1999-03-09 | — | — | US | disclosed |
| EP-0880074-A1 | An energy-sensitive resist material and a process for device fabrication using an energy-sensitive resist material | LUCENT TECHNOLOGIES INC. (US) | 1998-11-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090318652-A1 | NOVEL COMPOUND, POLYMER, AND RESIN COMPOSITION | ERCC4, RAD51, RTF1 | GPBAR1 4323/4885NR1H4 2361/4885PDE3A 3306/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.